Translational Transplantation Tolerance Cooperative Study Group
National Institutes of Health
Classification and identifiers
- Solicitation number
- RFA-AI-28-010
- Assistance listing (CFDA)
- 93.855
Amount
Amount not published by the funder
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission through the support of the Translational Transplantation Tolerance Cooperative Study Group (TTTCSG) program. The overarching goal of this program is to facilitate clinical translation of safe and effective transplant tolerance regimens that achieve long-term graft survival without the need for life-long administration of immunosuppressive drugs. This program will enable establishment of a multi-center, cooperative program dedicated to developing, optimizing, and evaluating approaches to induce and maintain immune tolerance to allogeneic transplants, which will be tested in translationally relevant models. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301...
Related opportunities
- Cooperative Program for Modeling Clinical TransplantationNational Institutes of Health
- Collaborative Network for Clinical Research on Immune ToleranceNational Institutes of Health
- Clinical Trials in Organ Transplantation in Children and AdultsNational Institutes of Health
- NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)National Institutes of Health
- Translational Centers Using Microphysiologic Systems for Infectious DiseasesNational Institutes of Health
- Translational Neural Devices (R61/R33 - Clinical Trial Optional)National Institutes of HealthCloses Jan 2027